
James P. Guevara
VerifiedUniversity of Pennsylvania · Rehabilitation Medicine
Active 1955–2026
About
James P. Guevara, MD, MPH, is a Professor of Pediatrics (General Pediatrics) at the Children's Hospital of Philadelphia and an Attending Physician there. He is also a Senior Fellow at the Leonard Davis Institute of Health Economics, a Senior Scholar at the Center for Clinical Epidemiology and Biostatistics (CCEB), and a Senior Fellow at the Center for Public Health Initiatives, all within the University of Pennsylvania. Dr. Guevara's research expertise includes developmental and behavioral disabilities, systematic reviews and meta-analyses, randomized controlled trials, and health disparities. His clinical expertise focuses on general and behavioral pediatrics. He holds a B.S. in Zoology from the University of California, Davis, an M.C.S. in Theology from New College Berkeley, an M.D. from Northwestern University, and an M.P.H. in Health Services from the University of Washington. His work emphasizes reducing disparities in early intervention services, promoting mental health screening, and improving health outcomes for underserved pediatric populations.
Research topics
- Medicine
- Family medicine
- Psychiatry
- Psychology
- Pediatrics
- Political Science
- Internal medicine
- Environmental health
- Developmental psychology
- Pedagogy
- Nursing
Selected publications
PEDIATRICS · 2026-03-09 · 1 citations
article1st authorCorrespondingOBJECTIVE: Disparities in early intervention (EI) use are well documented. We sought to determine the effects of family navigation (FN) on EI services use and child development among low-income, racially diverse children with suspected developmental delays. METHODS: We conducted a randomized controlled trial at 6 pediatric practices in a large urban community. Children who were aged younger than 30 months, had a gestational age of more than 35 weeks, had parents who spoke English or Spanish, and were referred to Part C EI were eligible. Children were randomized to FN or usual care and followed for 12 months. The main outcome measures were multidisciplinary evaluation (MDE) and EI service initiation and duration obtained from county EI program administrative files and Bayley-3 developmental scores. We examined differences among groups using intention-to-treat logistic and Cox regression models. RESULTS: We randomized 358 eligible children and followed 305 (85%) for 12 months. Children were predominantly Black with family incomes of less than $55 000. Overall, 257 (72%) completed an MDE, and 195 (54%) initiated services. Children who received FN had greater odds of MDE completion (adjusted odds ratio, 2.1; 95% CI, 1.2-3.5) and greater EI service initiation (64.4% vs 54.7%; P = .02) than children who received usual care. The average duration of EI services and Bayley-3 scores did not differ among groups. CONCLUSIONS: We found that an FN program improved EI referral completion and services initiation but not EI duration or child development among a population of predominantly low-income urban Black children. Implementation of FN programs in similar minoritized communities may reduce disparities in access to EI services.
Dynamic Duo: Managing Mentor-Mentee Relationships for High-Quality Publications
Academic Pediatrics · 2026-02-06
articleCell Genomics · 2026-03-09 · 2 citations
articleOpen accessLong-read whole-genome sequencing (LR-WGS) technologies enhance the discovery of structural variants (SVs) and tandem repeats (TRs). We performed LR-WGS on 267 individuals from 63 autism spectrum disorder (ASD) families and generated an integrated call set combining long- and short-read data. LR-WGS increased detection of gene-disrupting SVs and TRs by 33% and 38%, respectively, and enabled identification of novel exonic de novo germline and somatic SVs. We observed complex SV patterns, including a class of nested duplication-deletion events. By joint analysis of phased genetic variation and DNA methylation, we identified deletions of imprinted genes and demonstrated the effect of intermediate TR expansions (35-54 CGG) on the methylation of FMR1 promoter. Rare SVs, TRs, and damaging SNVs together accounted for 7.4% (95% confidence interval [CI], 2.7%-17%) of the heritability of ASD. These findings demonstrate how LR-WGS can resolve complex genetic variation and its functional consequences and regulatory effects in a single assay.
UNC Libraries · 2025-04-22
articleOpen accessmedRxiv · 2025-07-23 · 3 citations
preprintOpen accessLong–read whole genome sequencing (LR–WGS) technologies enhance the discovery of structural variants (SVs) and tandem repeats (TRs). We performed LR–WGS on 267 individuals from 63 ASD families and generated an integrated call set combining long– and short–read data. LR–WGS increased detection of gene–disrupting SVs and TRs by 33% and 38%, respectively, and enabled identification of novel exonic de novo germline and somatic SVs. We observed complex SV patterns, including a class of nested duplication–deletion events. By joint analysis of phased genetic variation and DNA methylation, we identified deletions of imprinted genes, and demonstrated the effect of intermediate TR expansions (35–54 CGG) on the methylation of FMR1 promoter. Rare SVs, TRs, and damaging SNVs together accounted for 7.4% (95% CI: 2.7–17%) of the heritability of ASD. These findings demonstrate how LR–WGS can resolve complex genetic variation and its functional consequences and regulatory effects in a single assay.
PEDIATRICS · 2025-08-25 · 10 citations
articleOpen accessRates of mental health, emotional, and behavioral (MEB) problems in the United States continue to rise, with current estimates of 13% to 20% of children having an MEB disorder and an additional 19% with problems causing impairment or distress that do not meet diagnostic criteria for a specific disorder. This clinical report incorporates and expands on recommendations from the 2019 American Academy of Pediatrics policy statement "Mental Health Competencies for Pediatric Practice" as well as "Recommendations for Preventive Pediatric Health Care." It addresses the rising MEB needs of youth since the previous clinical report, "Promoting Optimal Development: Screening for Behavioral and Emotional Problems," was published in 2015. This report outlines specific guidance for MEB screening, identification, and care of children in pediatric primary care. Screening, as part of regular health supervision visits and surveillance, begins within the first month of life to identify postpartum depression in caregivers. Child-focused screening for MEB problems begins at 6 months of age and continues at 12-, 24-, and 36-month health supervision visits, alternating with recommended developmental and autism spectrum disorder screenings at every visit in the Bright Futures Periodicity schedule and additionally when clinically indicated. After age 3, MEB screening continues annually. This report also 1) reviews updated information on prevalence of MEB problems; 2) articulates the current state of detection of these problems in pediatric primary care; 3) addresses how to manage a positive screen; 4) describes barriers to screening, including special population needs, and potential models to address those barriers; and 5) discusses potential changes at a practice and systems level that facilitate successful MEB screening.
Biological Psychiatry · 2025-04-09
article1st authorCorrespondingUNC Libraries · 2025-04-22
articleOpen accessBiological Psychiatry · 2025-04-09
articlemedRxiv · 2025-07-15 · 6 citations
preprintOpen accessAbstract Rare copy number variants (CNVs) are a key component of the genetic basis of psychiatric conditions, but have not been well characterized for most. We conducted a genome-wide CNV analysis across six diagnostic categories (N = 574,965): autism (ASD), ADHD, bipolar disorder (BD), major depressive disorder (MDD), PTSD, and schizophrenia (SCZ). We identified 35 genome-wide significant associations at 18 loci, including novel associations in SCZ ( SMYD3, USP7 - HAPSTR1 ) and in the combined cross-disorder analysis ( ASTN2 ). Rare CNVs accounted for 1–3% of heritability across diagnoses. In ASD, associations were uniformly positive, consistent with autism having diverse etiologies and clinical presentations. By contrast, CNVs showed a dose-dependent relationship for other diagnoses, including SCZ and PTSD, with reciprocal deletions and duplications having inversely correlated effects and distinct genotype-phenotype relationships. Our findings suggest that genes have effects that are both dose-dependent and pleiotropic, such that a positive influence on one dimension of psychopathology may be accompanied by positive or negative effects on others.
Recent grants
NIH · $1.3M · 2011
NIH · $894k · 2008
Frequent coauthors
- 61 shared
Stephen W. Scherer
SickKids Foundation
- 48 shared
Alexander G. Fiks
Children's Hospital of Philadelphia
- 44 shared
Jonathan Sebat
- 41 shared
Anne S. Bassett
Centre for Addiction and Mental Health
- 40 shared
Robert S. Gallagher
University of Pennsylvania
- 40 shared
Oanh Hong
- 40 shared
Ruben C. Gur
Lifespan
- 40 shared
Raquel E. Gur
Children's Hospital of Philadelphia
Education
- 1999
MPH, Health Services
University of Washington School of Public Health
- 1990
MD
Northwestern University - Chicago
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with James P. Guevara
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup